Liver diseases caused by viral infection, alcohol abuse and metabolic disorders can
progress to end‐stage liver failure, liver cirrhosis and liver cancer, which are a growing …

End‐stage liver fibrosis frequently progresses to portal vein thrombosis, formation of
oesophageal varices, hepatic encephalopathy, ascites, hepatocellular carcinoma and liver …

Mesenchymal stem cell (MSC) transplantation is a novel treatment for liver diseases due to
the roles of MSCs in regeneration, fibrosis inhibition and immune regulation. However, the …

Hepatic macrophages have been considered as a therapeutic target for liver fibrosis
treatment, and phosphatidylserine (PS)-containing nanoparticles are commonly used to …

Different hepatoxic factors cause irreversible liver injury, leading to liver failure, cirrhosis,
and cancer in mammals. Liver transplantation is the only effective strategy, which can …

Cardiac disease is the leading cause of mortality and disability worldwide. We investigated
the role of undifferentiated adipose tissue-derived mesenchymal stem cells (ADMSC) alone …

Materials and Methods: BM-MSCs viability, phenotypes, and proliferation were evaluated.
Hepatogenic differentiation, albumin, and mmmmmmmm-fetoprotein gene expression were …

Nanobiotechnology is the emerging science of two powerful technologies biotechnology
and nanotechnology, and it reflects science's growing ability to investigate beyond the …